Meta-Analysis
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. May 6, 2014; 5(2): 97-104
Published online May 6, 2014. doi: 10.4292/wjgpt.v5.i2.97
Table 1 Characteristic of studies included
Ref.Type of stentType of EVSRandomizedProspective studyConsecutive patientsComparable base-line dataDefinition of variceal rebleedingDefinition of post-TIPS HELost (TIPS/EVS)
Mahadeva et al[13]BareCyanoacrylateNoNoNoYesNRNR0/0
Lo et al[19]BareCyanoacrylateYesYesYesNoRebleeding from GV or EV was defined as the presence of hematemesis or melena with the bleeding source being endoscopically proven to originate from GV or EV, respectivelyPatients with altered consciousness levels and elevated arterial ammonia levels requiring hospitalization were recorded as having the complication of hepatic encephalopathy1/6
Procaccini et al[7]29 with covered stent, 15 with bare stentCyanoacrylateNoNoNRYesRebleeding was defined by a significant decrease in hemoglobin or hematocrit requiring packed red cell transfusion or evidence of hematemesis or melena with hemodynamic insufficiencyNRNR/NR